Clinical Trials

Regeneron Makes History: FDA Approves Otarmeni, the First Gene Therapy for Rare Genetic Hearing Loss NEW YORK — In a landmark victory …

The medical community is witnessing a paradigm shift in the treatment of congenital deafness, moving from the lifelong reliance on prosthetic hardware …

FDA Approves Merck’s Idvynso: A New Alternative for HIV Patients Switching from Biktarvy In a move that reshapes the competitive landscape of …

Nula Therapeutics Targets Metabolic Disease via Groundbreaking Nuclear Envelope Restoration In a significant leap for cellular medicine, Nula Therapeutics has emerged to …

FDA Grants Historic Approval to Filspari for Rare Kidney Disease FSGS WASHINGTON — In a watershed moment for nephrology, the U.S. Food …

Next-Gen Cancer Warfare: Sidewinder Therapeutics and Stipple Bio Secure Massive Funding to Revolutionize Antibody-Drug Conjugates NEW YORK — The landscape of precision …

Eli Lilly’s Foundayo Receives FDA Approval, Intensifying Competition in Weight Loss Medications In a significant development for individuals managing obesity and related …

Merck’s $6.7 Billion Terns Pharma Deal: A Strategic Move Against Novartis’s Cancer Dominance In a significant pharmaceutical maneuver, Merck has announced the …

Rezatapopt Restores Mutant p53 Function in Early Clinical Trial, Offering Hope for Cancer Treatment In a significant breakthrough for cancer research, a …

Gilead Sciences Expands Autoimmune Disease Portfolio with $1.7 Billion Ouro Medicines Acquisition In a significant move to bolster its presence in the …